期刊文献+

利用Gateway技术构建重组腺病毒pAd-NK4 被引量:6

Gateway technical supported construction of a recombinant adenovirus vector pAd-NK4
下载PDF
导出
摘要 目的利用Gateway技术构建含人肝细胞生长因子(HGF)NK4基因的重组腺病毒载体。方法以含有HGF/NK4基因的质粒为模板PCR扩增NK4基因,将回收的NK4PCR产物片段克隆至腺病毒穿梭载体pYr-adshuttle-6获得重组质粒pYr-adshuttle-6-NK4。从该重组质粒上,利用LR同源重组将NK4-IRES-EGPF表达框转移至腺病毒骨架质粒pAD/BL-DEST,获得重组腺病毒质粒pAd-NK4-IRES-EGFP。该质粒经pacI线性化后转染293包装细胞,获得重组腺病毒rAd-NK4-IRES-EGFP。采用TCID 50(tissue cell infectiousdosage 50,TCID 50)法测定重组腺病毒滴度。重组腺病毒分别经酶切和PCR等方法进行鉴定。荧光显微镜观察转染效果。结果证实腺病毒载体中含有NK4基因的目的片段;病毒滴度为6.3×1011 PFU.L-1;荧光显微镜发现该重组腺病毒能在HEK293细胞中高效的表达。结论利用Gateway技术可以快速地构建同时表达NK4蛋白和绿色荧光的重组腺病毒,为下一步开展关于NK4基因的肿瘤治疗提供了基础。 Aim To construct a recombinant adenovirus vector pAd-NK4 with Gateway technology.Methods The NK4 gene was amplified by PCR with plasmid con-taining hepatocyte growth factor(HGF)/NK4 as tem-plate,and then cloned into adenovirus adshuttle vector pYr-adshuttle-6 to acquire recombinant plasmid pYr-adshuttle-6-NK4,from which,the expression cassette of NK4-IRES-EGPF was transfered to pAD/BL-DEST with LR recombinant reaction to acquire recombinant adenovirus plasmid pAd-NK4-IRES-EGFP.The correct clone was linearized and transfected into 293A cells for packing and amplified adenovirus pAd-NK4 was obtained and identified.The titer was determined by TCID50.The transfection efficiency was observed under the fluorescent microscope.Results The recombinant adenovirus vector containing human NK4 gene was constructed successfully with the titer 6.3×1011 PFU·L-1.This vector was found to infect HEK293 cells efficiently.Conclusion The recombinant adenovirus expressing NK4 gene and green fluorescence can be successfully constructed with Gateway technology,which lays the foundation for further study.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第4期462-467,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30871111)
关键词 腺病毒 GATEWAY技术 人肝细胞生长因子 NK4 基因治疗 肿瘤 adenovirus Gateway technology hepatocyte growth factor NK4 gene therapy tumor
  • 相关文献

参考文献8

  • 1Camp R L, Rimn E B, Rimm D L. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma [ J ]. Cancer, 1999,86:2259 - 65.
  • 2刘永靖,陈飞虎,于奇,韩继彪,苏长青,钱其军.腺病毒载体携带人TRAIL基因治疗H446小细胞肺癌的体外实验研究[J].中国药理学通报,2007,23(6):755-759. 被引量:9
  • 3楼兴法,杨波.HGF/c-Met信号通路与肿瘤的关系及相关抗肿瘤药物的研究[J].药学进展,2007,31(11):486-491. 被引量:10
  • 4Giordano S, Ponzetto C, DiRenzo M F, et al. Tyrosine kinase receptor in distinguish able from the c-Met protein [ J ]. Nature, 1989,339 : 155 - 6.
  • 5Du W, Hattori Y, Yamada T, et al. NK4, an antagonist of hepatocyte growth factor (HGF) , inhibits growth of multiple myeloma cells : molecular targeting of angiogenie growth factor [ J ]. Blood, 2007,109:3042 - 9.
  • 6Bushman W, Thompson J F, Vargas L, et al. Control of directionality in lambda site specific recombination[ J]. Science, 1985,230 (4278) : 906 -11.
  • 7Pons E, Uphoff C C, Drexler H G. Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines[J]. Leuk Res, 1998, 22:797 -804.
  • 8顾洪生,程志安,李振宇,周文钰,邹小英.利用Gateway技术构建重组腺病毒载体pAd-LMP-1[J].中国组织工程研究与临床康复,2010,14(24):4425-4429. 被引量:4

二级参考文献34

共引文献20

同被引文献58

  • 1刘荣梅,张杰,高继国,宋福平.苏云金芽孢杆菌营养期杀虫蛋白基因vip3A的研究[J].高技术通讯,2004,14(9):39-42. 被引量:18
  • 2钟万芳,方继朝,郭慧芳,王节萍,刘宝生.广谱高效Bt菌株的筛选及其杀虫蛋白基因的克隆[J].华南农业大学学报,2005,26(4):40-42. 被引量:10
  • 3张秀艳,何国庆.蛋白质突变体基因库构建方法的研究进展[J].中国生物工程杂志,2006,26(10):52-58. 被引量:5
  • 4EstruchJ J, Warren GW, Mullins MA, et al. Vip3A, a novel Bacillus thuringiensis vegetative insecticidal protein with a wide spectrum of activities against lepidopteran insects[J] . Proc Nat! Acad Sci, 1996, 93 ( 11 ) : 5389-5394.
  • 5HartleyJL, Temple GF, Brasch MA. DNA cloning using in vitro site?specific recombination[J] . Genome Research, 2000, 10 : 1788-1795.
  • 6Suzuki Y, Kagawa N, Fujino T, et al. A novel high-throughputf HTP) cloning strategy for site-directed designed chimeragenesis and mutation using the Gateway cloning system[J] . Nucleic Acids Res, 2005,33 ( 12) : el09.
  • 7Stemmer WPC. Rapid evolution of a protein in vitro by DNA shuffl?ing[J] . Nature, 1994,370 (6488) : 389-391.
  • 8Zhao H, Giver L, Shao Z, et al. Molecular evolution by staggered extension process (StEP) in vitro recombination[J] . Nature Biotechnology, 1998, 16 (3) : 258-261.
  • 9Coco WM, Levinson WE, Crist MJ, et al. DNA shuffling method for generating highly recombined genes and evolved enzymes[J] . Nature Biotechnology, 2001,19 (4) : 354-359.
  • 10Sen S, Venkata Dasu V, Mandal B. Developments in directed evol?ution for improving enzyme functions[J] . Applied Biochemistry and Biotechnology, 2007, 143 (3) : 212-223.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部